Christopher Nobo, MD
Gastroenterology · Riverview, FLNPI 1407167919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $913 and has fallen 72.8% since, to $249 in 2025. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.
Across 138 payments — averaging $23.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$611
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$545
- Johnson & Johnson$529
- Olympus America Inc.$460
- Vivus LLC$128
- Janssen Scientific Affairs, LLC$121
- plus $785 from 18 others
Across 1 payment — averaging $12.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$12
What the payments were for
- Food & beverage$3,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $611 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $545 |
| Johnson & Johnson | 11 | $529 |
| Olympus America Inc. | 5 | $460 |
| Vivus LLC | 7 | $128 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| Boston Scientific | 3 | $106 |
| Cook Medical LLC | 1 | $102 |
| Gilead | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $85 |
| Bristol Myers Squibb | 4 | $82 |
| Evoke Pharma, Inc. | 4 | $60 |
| Intercept Pharmaceuticals, Inc. | 2 | $40 |
| Ironwood Pharmaceuticals, Inc | 2 | $38 |
| Merck | 2 | $32 |
| Novo Nordisk | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Alcresta Therapeutics, Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| QOL Medical, LLC | 1 | $14 |
| UCB, Inc. | 1 | $13 |
| Braintree Laboratories, Inc. | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELARA$376
- Tremfya$229
- EVIS EXERA lll COLONOVIDEOSCOPE$145
- Olympus Biliary Devices$108
- Instinct$102
How this compares
$3,179 in reported general payments places this provider in the 50th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Riverview
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.